Clinical Trial Update: Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac [Phase 4]

View source ↗

Summary

Phase 4 trial update on cervicovaginal immune responses to intramuscular TicoVac dosing; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• TicoVac (Tick-borne encephalitis vaccine (inactivated))

Snippet

Sponsor: University of Surrey | Conditions: Tick-Borne Encephalitis | Phase 4 | Status: COMPLETED